Shukun Technology Gets 590 Million Yuan

Shukun Technology announced the completion of a new round of RMB 590 million in financing. Since the beginning of this year, the accumulated financing amount of Shukun Technology has reached nearly 1 billion yuan. This round of financing was led by Sequoia Capital China Fund, with China Re and Zhongjin Pucheng as co-investors. Old shareholders HG Capital, 5Y Capital, CCV, Qiming Venture Capital, and Marathon Venture continued to co-invest. China Renaissance Capital served as the exclusive financing for this financing. consultant.

 continue to improve the core technology product line of "digital human body", further accelerate the deployment of products in medical institutions at all levels, and accelerate the development of digital medical productivity in the process of intelligent construction of hospitals across the country. all covered.

Although 2020 is full of challenges, Shukun Technology still achieved outstanding results: the development of new crown pneumonia AI for fighting the epidemic was commended by the Ministry of Industry and Information Technology, and was invited to attend the Beijing Municipal Government's new crown pneumonia press conference to report on the scientific and technological anti-epidemic results; "Digital Heart" won The first three-category card in the field of cardiac stenosis in China.

The "Digital Brain" joint scientific research article was published in the Nature series and won the first prize of the Beijing Medical Association Competition; cooperated with the regional health committee to create a "digital doctor by the people"; Shukun AI has repeatedly entered the health committee and the Chinese Hospital Association , People’s Daily, “Healthy China”, Beijing Medical Association and other authoritative institutions, many head hospitals across the country reported the application cases of Shukun AI assisting the intelligent construction of hospitals; near the end of the year, the company was selected as the authoritative Silicon Valley media Top two Chinese companies in the "50 Most Promising Startups" selection by Information.

Apart from being able to apply its technology to more organs and other clinical abnormalities like tumours, Shukun Technology also intends to use the freshly raised capital to make its technology accessible in all levels of hospitals, as well as enhance the medical competencies of grassroots-level clinics. With the paired combination of machine and human expertise in its approach, Shukun Technology aims to improve the level and efficacy of the medical service for key stakeholders.

Sequoia Capital China is a VC firm focused on seed stage, mid stage, late stage, and growth investments in the fintech sector. Beijing, Beijing, China